| Effect of aspirin on cardiovascular events and bleeding in the healthy elderly JJ McNeil, R Wolfe, RL Woods, AM Tonkin, GA Donnan, MR Nelson, ... New England Journal of Medicine 379 (16), 1509-1518, 2018 | 859 | 2018 |
| Effect of aspirin on all-cause mortality in the healthy elderly JJ McNeil, MR Nelson, RL Woods, JE Lockery, R Wolfe, CM Reid, ... New England Journal of Medicine 379 (16), 1519-1528, 2018 | 651 | 2018 |
| Effect of aspirin on disability-free survival in the healthy elderly JJ McNeil, RL Woods, MR Nelson, CM Reid, B Kirpach, R Wolfe, E Storey, ... New England Journal of Medicine 379 (16), 1499-1508, 2018 | 399 | 2018 |
| The epigenetic clock as a predictor of disease and mortality risk: a systematic review and meta-analysis PD Fransquet, J Wrigglesworth, RL Woods, ME Ernst, J Ryan Clinical epigenetics 11 (1), 1-17, 2019 | 174 | 2019 |
| Impact of a premature menopause on cognitive function in later life J Ryan, J Scali, I Carriere, H Amieva, O Rouaud, C Berr, K Ritchie, ... BJOG: An International Journal of Obstetrics & Gynaecology 121 (13), 1729-1739, 2014 | 170 | 2014 |
| Toward potent ghrelin receptor ligands based on trisubstituted 1, 2, 4-triazole structure. 2. Synthesis and pharmacological in vitro and in vivo evaluations A Moulin, L Demange, G Bergé, D Gagne, J Ryan, D Mousseaux, A Heitz, ... Journal of medicinal chemistry 50 (23), 5790-5806, 2007 | 139 | 2007 |
| Postnatal stability, tissue, and time specific effects of AHRR methylation change in response to maternal smoking in pregnancy B Novakovic, J Ryan, N Pereira, B Boughton, JM Craig, R Saffery Epigenetics 9 (3), 377-386, 2014 | 133 | 2014 |
| EFFECTS OF CARVEDILOL, A VASODILATOR-BETA-BLOCKER, IN PATIENTS WITH CONGESTIVE-HEART-FAILURE DUE TO ISCHEMIC-HEART-DISEASE H Krum, A Tonkin, A Trotter, R Burton, J Garrett, G Lane, D OWENSBY, ... Circulation 92 (2), 212-218, 1995 | 132 | 1995 |
| Late-life depression and mortality: influence of gender and antidepressant use J Ryan, I Carriere, K Ritchie, R Stewart, G Toulemonde, JF Dartigues, ... The British Journal of Psychiatry 192 (1), 12-18, 2008 | 126 | 2008 |
| BDNF promoter methylation and genetic variation in late-life depression V Januar, ML Ancelin, K Ritchie, R Saffery, J Ryan Translational psychiatry 5 (8), e619-e619, 2015 | 115 | 2015 |
| A prospective study of the association between endogenous hormones and depressive symptoms in postmenopausal women J Ryan, H Burger, C Szoeke, P Lehert, ML Ancelin, L Dennerstein Menopause (New York, NY) 16 (3), 509, 2009 | 114 | 2009 |
| Synthesis and pharmacological in vitro and in vivo evaluations of novel triazole derivatives as ligands of the ghrelin receptor. 1 L Demange, D Boeglin, A Moulin, D Mousseaux, J Ryan, G Bergé, ... Journal of medicinal chemistry 50 (8), 1939-1957, 2007 | 113 | 2007 |
| Epigenetics and depressive disorders: a review of current progress and future directions V Januar, R Saffery, J Ryan International journal of epidemiology 44 (4), 1364-1387, 2015 | 106 | 2015 |
| Life-time estrogen exposure and cognitive functioning in later life J Ryan, I Carrière, J Scali, K Ritchie, ML Ancelin Psychoneuroendocrinology 34 (2), 287-298, 2009 | 102 | 2009 |
| DNA-methylation-dependent alterations of claudin-4 expression in human bladder carcinoma S Boireau, M Buchert, MS Samuel, J Pannequin, JL Ryan, A Choquet, ... Carcinogenesis 28 (2), 246-258, 2007 | 94 | 2007 |
| The role of oxytocin receptor gene (OXTR) DNA methylation (DNAm) in human social and emotional functioning: a systematic narrative review C Maud, J Ryan, JE McIntosh, CA Olsson BMC psychiatry 18, 1-13, 2018 | 91 | 2018 |
| Hormone levels and cognitive function in postmenopausal midlife women J Ryan, FZ Stanczyk, L Dennerstein, WJ Mack, MS Clark, C Szoeke, ... Neurobiology of aging 33 (3), 617. e11-617. e22, 2012 | 90 | 2012 |
| A systematic review and meta-analysis of environmental, lifestyle, and health factors associated with DNA methylation age J Ryan, J Wrigglesworth, J Loong, PD Fransquet, RL Woods The Journals of Gerontology: Series A 75 (3), 481-494, 2020 | 86 | 2020 |
| Regulation of ERK1/2 activity by ghrelin‐activated growth hormone secretagogue receptor 1A involves a PLC/PKCɛ pathway D Mousseaux, L Le Gallic, J Ryan, C Oiry, D Gagne, JA Fehrentz, ... British journal of pharmacology 148 (3), 350-365, 2006 | 86 | 2006 |
| Characteristics of hormone therapy, cognitive function, and dementia: the prospective 3C Study J Ryan, I Carrière, J Scali, JF Dartigues, C Tzourio, M Poncet, K Ritchie, ... Neurology 73 (21), 1729-1737, 2009 | 84 | 2009 |
John McNeilProfessor and Head, School of Public Health and Preventive Medicine, Monash University在 monash.edu 的电子邮件经过验证
